doi: 10.1016/0006-291x(89)91143-1.
'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation
Affiliations
- PMID: 2783143
- DOI: 10.1016/0006-291x(89)91143-1
Item in Clipboard
'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation
Biochem Biophys Res Commun.
.
Abstract
The osteoclast is unique in its capacity to resorb bone. An unbalanced increase in this activity causes osteoporosis, a crippling bone disease that poses a major public health problem. Despite this, our understanding of osteoclast regulation is very limited. Calcitonin is the only known physiological inhibitor of osteoclast function. We demonstrate here for the first time that the concentration of calcium ions at the resorptive site directly regulates osteoclast function by modulating the intracellular free calcium concentration. This represents an important feedback mechanism of osteoclast control.
Similar articles
-
Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor".J Cell Physiol. 1991 Dec;149(3):422-7. doi: 10.1002/jcp.1041490310. J Cell Physiol. 1991. PMID: 1660481
-
Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations.Endocrinology. 1994 Sep;135(3):996-1003. doi: 10.1210/endo.135.3.8070395. Endocrinology. 1994. PMID: 8070395
-
Intracellular calcium in the control of osteoclast function. I. Voltage-insensitivity and lack of effects of nifedipine, BAYK8644 and diltiazem.Biochem Biophys Res Commun. 1990 Feb 28;167(1):183-8. doi: 10.1016/0006-291x(90)91748-h. Biochem Biophys Res Commun. 1990. PMID: 1690001
-
Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2936-40. doi: 10.1073/pnas.88.7.2936. Proc Natl Acad Sci U S A. 1991. PMID: 1849281 Free PMC article.
-
Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.Adv Drug Deliv Rev. 2005 May 25;57(7):959-71. doi: 10.1016/j.addr.2004.12.018. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15876398 Review.
Cited by
-
Honeycomb blocks composed of carbonate apatite, β-tricalcium phosphate, and hydroxyapatite for bone regeneration: effects of composition on biological responses.Mater Today Bio. 2019 Sep 24;4:100031. doi: 10.1016/j.mtbio.2019.100031. eCollection 2019 Sep. Mater Today Bio. 2019. PMID: 32159156 Free PMC article.
-
A ryanodine receptor-like molecule expressed in the osteoclast plasma membrane functions in extracellular Ca2+ sensing.J Clin Invest. 1995 Sep;96(3):1582-90. doi: 10.1172/JCI118197. J Clin Invest. 1995. PMID: 7657829 Free PMC article.
-
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.J Cell Biol. 1999 May 3;145(3):527-38. doi: 10.1083/jcb.145.3.527. J Cell Biol. 1999. PMID: 10225954 Free PMC article.
-
The effect of extracellularly applied divalent cations on cytosolic Ca2+ in murine leydig cells: evidence for a Ca2+-sensing receptor.J Physiol. 1998 Dec 1;513 ( Pt 2)(Pt 2):399-410. doi: 10.1111/j.1469-7793.1998.399bb.x. J Physiol. 1998. PMID: 9806991 Free PMC article.
-
Bone resorption by osteoclasts involves fine tuning of RHOA activity by its microtubule-associated exchange factor GEF-H1.Front Physiol. 2024 Jan 19;15:1342024. doi: 10.3389/fphys.2024.1342024. eCollection 2024. Front Physiol. 2024. PMID: 38312316 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
